- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01896089
Regional Kidney Paired Donor Exchange in Sensitized Patients
Prospective, Multicenter, Observational Registry Study to Determine if Enrollment in a Regional Kidney Paired Donor Exchange Program Improves the Overall Rate of Kidney Transplantation in Sensitized Patients, and Sensitized Patients Undergoing Desensitization Treatments.
Study Overview
Status
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98101
- Recruiting
- Virginia Mason Medical Center
-
Contact:
- Donald Rodriguez
- Phone Number: 206-342-6958
- Email: donald.rodriguez@vmmc.org
-
Principal Investigator:
- Andrew Weiss, MD
-
Seattle, Washington, United States, 98104
- Recruiting
- Swedish Medical Center
-
Contact:
- Terri Spinelli
- Phone Number: 206-215-3063
- Email: terri.spinelli@swedish.org
-
Principal Investigator:
- Lisa Florence, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
A. Potential Recipients must meet the following inclusion criteria:
- Willing and able to sign an informed consent form
- Must be at least 18 years old
- Meet all recipient selection criteria of the transplant center
- Listed on the deceased donor kidney waiting list for renal transplant at a participating center
- Potential recipients must:
Group 1: have one or more medically suitable donors who are ABO incompatible or HLA incompatible (defined as positive serologic cross-match); or
Group 2: have a medically suitable donor that is otherwise deemed incompatible due to age, size, or other mismatch by their respective transplant center; or
Group 3: be listed on the deceased donor waiting list for ≥ one year without an identifiable living donor and have a PRA% ≥ 60%
B. Potential Living Donors must meet the following inclusion criteria:
- Must provide informed consent in accordance with the process outlined in the Informed Consent Requirements Section of the KPD Program Manual of Operations
- Must be at least 18 years old
- Meet all living donor selection criteria of the transplant center
- Meet the evaluation requirements set forth in the Living Donor Evaluation Section of the KPD Program Operational Guidelines
Exclusion Criteria:
C. Recipients
- Do not meet selection criteria of the transplant center
- Eligible compatible donor at the time of enrollment
- Inactive (not eligible to receive a kidney) on the deceased donor waitlist
- Pregnant or breast feeding
D. Donors
- Unwilling or unable to provide informed consent
- Have identified barriers to donation as set forth in the Living Donor Evaluation Section of the KPD Program Manual of Operations (Appendix A)
- Must not be currently listed as a potential living donor for any other recipient registered in the KPD system
- Pregnant or breast feeding
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The rate of kidney transplant in sensitized patients following desensitization and enrollment in a regional kidney paired donor exchange program
Time Frame: 24 months
|
The rate of kidney transplant in sensitized patients following desensitization and enrollment in a regional kidney paired donor exchange program will be summarized.
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall number of kidney transplants per center/region
Time Frame: 24 months
|
To determine the overall number of kidney transplants per center/region.
|
24 months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The overall number of KPD matches in the region
Time Frame: 24 months
|
24 months
|
Donor types (direct, paired exchange, altruistic)
Time Frame: 24 months
|
24 months
|
The overall number of KPD exchange recipients transplanted in the region
Time Frame: 24 months
|
24 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lisa Florence, MD, Swedish Medical Center
- Principal Investigator: Andrew Weiss, MD, Virginia Mason Medical Center
- Principal Investigator: Douglas Norman, MD, Oregon Health and Science University
- Principal Investigator: Richard Carson, MD, Sacred Heart Medical Center (Spokane)
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- KPD6172013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on The Rate of Kidney Transplants in Sensitized Patients.
-
Hansa Biopharma ABActive, not recruitingKidney Transplantation in Highly Sensitized PatientsUnited States
-
Seoul National University Bundang HospitalUnknownThe Reduction of Aspiration Rate in Intubated PatientsKorea, Republic of
-
Hansa Biopharma ABRecruitingKidney Transplantation in Highly Sensitized PatientsUnited States
-
Hansa Biopharma ABRecruitingKidney Transplantation in Highly Sensitized PatientsUnited States
-
Hansa Biopharma ABRecruitingKidney Transplantation in Highly Sensitized PatientsSpain, Italy, France, Netherlands, Belgium, Austria, Czechia, Sweden, United Kingdom, Slovenia
-
Copenhagen Trial Unit, Center for Clinical Intervention...The Info Trial Group; Charlotte Behnke; Pia Caspersen; Dorte Fischer; Rolf I. Hansen and other collaboratorsCompletedAmbulatory Patients in the Dep. of Medical Gastroenterology | Ambulatory Patients in the Dep. of Gynecology | Ambulatory Patients in the Dep. of Orthopedic Surgery | Ambulatory Patients in the Dep. of UrologyDenmark
-
Hansa Biopharma ABRecruitingKidney Transplantation in Highly Sensitized PatientsSpain, Finland, Sweden
-
Assiut UniversityUnknownThe Difference in Estimation of Split Renal Function Using the Two Radiopharmaceuticals:Tc-99m DTPA & Tc-99m DMSA in Kidney Patients
-
Centre Hospitalier Intercommunal CreteilNot yet recruitingthe Rate of Participation in Screening for PBC
-
Loughborough UniversityEntrinsic Beverage Company LLCCompletedRate of Water Appearance/Delivery in the Blood | Water BalanceUnited Kingdom